Trial Profile
A Randomized, Double-blind, Placebo-controlled Cross-over Study to Investigate the Effect of GSK1014802 on Ambulatory Blood Pressure
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Jul 2023
Price :
$35
*
At a glance
- Drugs Vixotrigine (Primary)
- Indications Bipolar disorders
- Focus Pharmacodynamics
- Sponsors Biogen; GlaxoSmithKline; GSK
- 24 Aug 2018 Results published in the Journal of Clinical Pharmacology
- 12 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jan 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.